Patents by Inventor Jeffrey R. Luber

Jeffrey R. Luber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Systems for Determining Autism Spectrum Disorder Risk
    Publication number: 20240133865
    Abstract: In certain embodiments, the invention stems from the discovery that analysis of population distribution curves of metabolite levels in blood can be used to facilitate predicting risk of autism spectrum disorder (ASD) and/or to differentiate between ASD and non-ASD developmental delay (DD) in a subject. In certain aspects, information from assessment of the presence, absence, and/or direction (upper or lower) of a tail effect in a metabolite distribution curve is utilized to predict risk of ASD and/or to differentiate between ASD and DD.
    Type: Application
    Filed: May 24, 2023
    Publication date: April 25, 2024
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Ute Geigenmuller, Doris Damian, Maciej Pacula, Mark A. DePristo, Jeffrey R. Luber
  • Methods and systems for determining autism spectrum disorder risk
    Patent number: 11674948
    Abstract: In certain embodiments, the invention stems from the discovery that analysis of population distribution curves of metabolite levels in blood can be used to facilitate predicting risk of autism spectrum disorder (ASD) and/or to differentiate between ASD and non-ASD developmental delay (DD) in a subject. In certain aspects, information from assessment of the presence, absence, and/or direction (upper or lower) of a tail effect in a metabolite distribution curve is utilized to predict risk of ASD and/or to differentiate between ASD and DD.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: June 13, 2023
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Ute Geigenmuller, Doris Damian, Maciej Pacula, Mark A. DePristo, Jeffrey R. Luber
  • Methods and Systems for Determining Autism Spectrum Disorder Risk
    Publication number: 20180348199
    Abstract: In certain embodiments, the invention stems from the discovery that analysis of population distribution curves of metabolite levels in blood can be used to facilitate predicting risk of autism spectrum disorder (ASD) and/or to differentiate between ASD and non-ASD developmental delay (DD) in a subject. In certain aspects, information from assessment of the presence, absence, and/or direction (upper or lower) of a tail effect in a metabolite distribution curve is utilized to predict risk of ASD and/or to differentiate between ASD and DD.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 6, 2018
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Ute Geigenmuller, Doris Damian, Maciej Pacula, Mark A. DePristo, Jeffrey R. Luber
  • Methods and systems for determining autism spectrum disorder risk
    Patent number: 10041932
    Abstract: In certain embodiments, the invention stems from the discovery that analysis of population distribution curves of metabolite levels in blood can be used to facilitate predicting risk of autism spectrum disorder (ASD) and/or to differentiate between ASD and non-ASD developmental delay (DD) in a subject. In certain aspects, information from assessment of the presence, absence, and/or direction (upper or lower) of a tail effect in a metabolite distribution curve is utilized to predict risk of ASD and/or to differentiate between ASD and DD.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: August 7, 2018
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Ute Geigenmuller, Doris Damian, Maciej Pacula, Mark A. DePristo, Jeffrey R. Luber
  • METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK
    Publication number: 20160091480
    Abstract: In certain embodiments, the invention stems from the discovery that analysis of population distribution curves of metabolite levels in blood can be used to facilitate predicting risk of autism spectrum disorder (ASD) and/or to differentiate between ASD and non-ASD developmental delay (DD) in a subject. In certain aspects, information from assessment of the presence, absence, and/or direction (upper or lower) of a tail effect in a metabolite distribution curve is utilized to predict risk of ASD and/or to differentiate between ASD and DD.
    Type: Application
    Filed: September 25, 2015
    Publication date: March 31, 2016
    Inventors: Ute Geigenmuller, Doris Damian, Maciej Pacula, Mark A. DePristo, Jeffrey R. Luber
  • METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK
    Publication number: 20150294081
    Abstract: In certain embodiments, the invention stems from the discovery that analysis of population distribution curves of metabolite levels in blood can be used to facilitate predicting risk of autism spectrum disorder (ASD) and/or to differentiate between ASD and non-ASD developmental delay (DD) in a subject. In certain aspects, information from assessment of the presence, absence, and/or direction (upper or lower) of a tail effect in a metabolite distribution curve is utilized to predict risk of ASD and/or to differentiate between ASD and DD.
    Type: Application
    Filed: September 22, 2014
    Publication date: October 15, 2015
    Inventors: Ute Geigenmuller, Doris Damian, Maciej Pacula, Mark A. DePristo, Jeffrey R. Luber, Stanley N. Lapidus